MetLife Inc. (NYSE:MET) finished Thursday with a subtraction of -$1.05 to close at $63.47, a downside of -1.63 percent. An average of 5,521,260 shares of common stock have been traded in the last five days. There was a fall of -$2.22 in the past week, and it reached a new high 22 times over the past 12 months. The last 20 days have seen an average of 4,543,245 shares traded, while the 50-day average volume stands at 4,226,380.
MET stock has decreased by -3.35% in the last month. The company shares reached their 1-month lowest point of $63.17 on 09/01/22. With the stock rallying to its 52-week high on 04/21/22, shares of the company touched a low of $57.05 and a high of $73.18 in 52 weeks. It has reached a new high 16 times so far this year and achieved 1.57% or $0.98 in price. In spite of this, the price is down -13.27% from the 52-week high.
Top 5 Cheap Stocks to Own Right Now
While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, "Top 5 Cheap Stock to Own Right Now", we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest.
Sign up here to get your free report now. .
35 days have passed since MetLife Inc. (MET) last reported insider trading activity. Goulart Steven J, who is EVP & Chief Risk Officer, most recently acquired $4,060 shares at $67.60 per share on Aug 19. In this transaction, the insider spent $274,456. EVP & Chief Risk Officer, DEBEL MARLENE, disposed of 4,060 shares at a price of $67.60 on Aug 19. The insider now owns more than $274,456 worth of shares. Prior to that, EVP & Chief Investment Officer Goulart Steven J went on to Sale 56,857 shares at $70.29 each on Feb 08. An amount of $3,996,376 was transacted.
MetLife Inc. (MET) has a trailing price-to-earnings (P/E) ratio of 15.81. The stock’s beta is 1.04. Other valuation ratios to consider include the trailing price-to-sales (P/S) ratio at 0.75, the price-to-book (PB) ratio at 1.39, and the price-to-cash flow ratio at 3.75.
The company has a payout ratio of 47.90%. The company’s most recent quarterly dividend payment was $0.50 a share, without any change from last year. Its latest increase dividend $0.02 reported on Tuesday April 26 2022.
Further, the company has a long term debt to equity ratio of 0.45 and a total debt to equity ratio of 0.46 for the quarter ending March 30. Its gross profit as reported stood at $8.13 billion compared to revenue of $71.08 billion.
For investors, determining the potential profitability of the investment also depends on the performance of the company’s management. In the past 12 months, MetLife Inc.’s return on assets was 0.50%.
For the three-month period that ended March 30, MetLife Inc. had $741.0 million in total debt. In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $103.0 million in the quarter, while revenues were shrunk -3167.96%. The analyst consensus anticipated MetLife Inc.’s latest quarter earnings to come in at $1.65 per share, but it turned out to be $2.08, a 26.10% surprise. For the quarter, EBITDA amounted to -$2.0 million. At the end of the quarter ending March 30, MetLife Inc.’s stock balance sheet showed total debt was $110.15 billion. Shareholders own equity worth $797.61 million.
From a technical analysis perspective, let’s take a brief look at MetLife Inc. (MET) price momentum. RSI 9-day as of the close on 22 September was 34.28%, suggesting the stock is Neutral, with historical volatility in this time frame at 21.79%.
As of today, MET’s price is $64.97 -3.38% or -$2.22 from its 5-day moving average. MET is currently trading -3.89% lower than its 20-day SMA and -3.36% lower than its 100-day SMA. However, the stock’s current price level is +5.87% above the SMA50 and +6.37% above the SMA200.
The stochastic %K and %D were 22.17% and 34.67%, respectively, and the average true range (ATR) was 1.55. With the 14-day stochastic at 2.68% and the average true range at 1.51, the RSI (14) stands at 40.34%. The stock has reached -1.28 on the 9-day MACD Oscillator while the 14-day reading was at -1.41.
Raymond James launched coverage on MetLife Inc. (NYSE: MET) in its analyst report released on September 22, 2022. The firm assigned the stock a Mkt perform rating. The consensus rating for MetLife Inc. (MET) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell MET, while 1 suggest investors hold. There are 1 analyst who rate the stock as underweight. The stock is rated overweight by 2 analysts, while 15 others rate it as a “buy”.
What is MET’s price target for the next 12 months?
Analysts predict a range of price targets between $74.00 and $83.00, with a median target of $77.00. Taking a look at these predictions, the average price target given by analysts for MetLife Inc. (MET) stock is $77.53.